# Teriparatide then denosumab in premenopausal osteoporosis

Source: https://pepvault.app/research/teriparatide-shane-2022

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Teriparatide](https://pepvault.app/research#teriparatide)

Clinical trial · people

# Teriparatide then denosumab: 21.9% spine bone density gain

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

For people using teriparatide, this study shows that following it with denosumab kept raising bone density in premenopausal women with severe osteoporosis.

- **Kind:** Clinical trial
- **Studied in:** People
- **Number studied:** 32
- **Published:** 2022
- **Journal:** J Clin Endocrinol Metab

## What they tested

The team wanted to see what 12 and 24 months of denosumab does to bone in premenopausal women with idiopathic osteoporosis (bone loss with no known cause) who had just finished 24 months of teriparatide.

## How the study was done

A preplanned phase 2B extension study with no comparison group. Women who had completed teriparatide received the trial's denosumab schedule of 60 mg every 6 months for 24 months; 32 took it for 12 months and 29 for 24 months.

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

On denosumab, bone mineral density (BMD) at the lumbar spine rose 5.2% at 12 months and 6.9% at 24 months. The total hip rose 2.9% and 4.6%, and the femoral neck rose 3.0% and 4.7%. Across the full 24 months of teriparatide plus 24 months of denosumab, BMD rose 21.9% at the lumbar spine, 9.8% at the total hip and 9.5% at the femoral neck, all statistically significant. Trabecular bone score, a score of the spongy inner bone's structure, rose 5.8%; blood markers of bone turnover fell 75% to 85% by 3 months and stayed low through 12 months, and denosumab was generally well tolerated.

## What it doesn’t show

This was a small extension study with no control group, so it can't show how this sequence compares with teriparatide alone or another follow-up drug. It included only premenopausal women with severe idiopathic osteoporosis, and it measured bone density and markers rather than fracture rates.

## The paper

Shane et al. Denosumab After Teriparatide in Premenopausal Women With Idiopathic Osteoporosis. J Clin Endocrinol Metab. 2022.

- [PubMed (PMID 34849989)](https://pubmed.ncbi.nlm.nih.gov/34849989/)
- [The paper (DOI 10.1210/clinem/dgab850)](https://doi.org/10.1210/clinem/dgab850)
- [ClinicalTrials.gov (NCT02049866)](https://clinicaltrials.gov/study/NCT02049866)

## The compound

- [Teriparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

## More studies on Teriparatide

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) Meta-analysis · people · 2025
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024) Meta-analysis · people · 2024
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Teriparatide: more bony union at 6 months than zoledronate after PLIF](https://pepvault.app/research/teriparatide-xiong-2022) Randomized trial · people · 2022
- [Teriparatide: 45.4% of jaw osteonecrosis lesions resolved by 52 weeks](https://pepvault.app/research/teriparatide-sim-2020) Randomized trial · people · 2020
- [Teriparatide: fewer new vertebral fractures than risedronate in VERO](https://pepvault.app/research/teriparatide-vero-2018) Randomized trial · people · 2018
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [Bone mineral density (BMD)](https://pepvault.app/glossary/bone-mineral-density)

<!--promo-->

PepVault for iPhone

## Taking teriparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Teriparatide](https://pepvault.app/research#teriparatide)

## The library

- [Teriparatide](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
